Global alliance between MDC and Crown Bioscience delivers advanced preclinical solutions for radiopharmaceutical innovators in oncology and diagnostics.
Crown Bioscience San Diego earns CLIA certification, enhancing clinical trial support with compliant, high-quality biomarker testing for drug development.
Crown Bioscience promotes Alex Slater to Chief Business Officer, reinforcing global commercial excellence and client-focused growth in oncology CRO services.